▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #803 by analyst upside · 2026-06-27
SKIN
SkinHealth Systems Inc.
Consumer Defensive · Market Cap $86M · P/E 0x
ANALYST PRICE TARGET
+103.3%
implied upside to consensus target
Current Price $0.66
Consensus Target $1.34
Bull Target $2.0
Bear Target $1.0
Analysts Covering 6
ANALYST CONSENSUS — HOLD
Strong Buy
0
Buy
1
Hold
4
Sell
1
52-Week Low $0.55
52-Week High $2.69
YTD Return -52.9%
FUNDAMENTALS
Market Cap $86M
P/E Ratio (TTM) N/A
Forward P/E 4.4x
EPS (TTM) $-0.13
PEG Ratio 0.93
Dividend Yield N/A
Revenue (TTM) $296M
Profit Margin -2.0%
52-WEEK RANGE
52-Week Low $0.55
52-Week High $2.69
Current Price $0.66
Bear Target $1.0
Bull Target $2.0
● Now $0.66 ● Target $1.34
TRADING DATA
Avg Volume 1.2M
YTD Return -52.9%
Analyst Count 6
Consensus Hold
Upside to Target +103.3%
Last Updated 2026-06-27

ANALYST SUMMARY

SkinHealth Systems Inc. (SKIN) is currently trading at $0.66 with a Wall Street consensus price target of $1.34, implying potential upside of 103.3% over the next 12 months. 6 analysts currently cover SKIN, with a consensus rating of Hold — 17% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $2.0, while the most cautious has a target of $1.0.

SKIN operates in the Consumer Defensive sector with a market capitalisation of $86M. The stock is down 52.9% year-to-date and is currently trading near the lower end of its 52-week range of $0.55 – $2.69.

SIMILAR STOCKS

Other Consumer Defensive stocks with comparable size and valuation.

USNA +88.4%
USANA Health Sciences, Inc.
$382M · P/E 41.4x · Hold
NATR +66.5%
Nature's Sunshine Products, Inc.
$370M · P/E 19.1x · Buy
FDP +78.0%
Del Monte Corporation
$1B · P/E 20.2x · Buy
NGVC +44.3%
Natural Grocers by Vitamin Cottage, Inc.
$740M · P/E 15.4x · Buy
HLF +46.2%
Herbalife Ltd.
$1B · P/E 5.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for SKIN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Roth Capital reit
Buy → Buy 2026-05-20 Building track record
Canaccord Genuity — Reiterated
Hold → Hold 2026-05-01 Building track record
TD Cowen — Reiterated
Hold → Hold 2026-03-16 Building track record
Canaccord Genuity — Reiterated
Hold → Hold 2026-03-13 Building track record
TD Cowen — Reiterated
Hold → Hold 2026-01-21 Building track record
TD Cowen — Reiterated
Hold → Hold 2025-09-22 Building track record
Roth Capital ● Initiated
Buy 2025-09-19 Building track record
Canaccord Genuity — Reiterated
Hold → Hold 2025-05-05 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →